SB 341 — Pharmaceuticals: adverse drug reactions: Drug Safety and Effectiveness Program.
Last action — Returned to Secretary of Senate pursuant to Joint Rule 56.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed Assembly
-
5To Executive
-
6Enacted
This bill died with 2009-2010 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of food, drugs, and cosmetics, under the administration of the State Department of Public Health. This bill would require the department to make every effort to enter into a contract or agreement with the University of California to establish a program, implemented only with federal or private funds or both, to evaluate the safety and effectiveness of prescription drugs in California. This bill would require, if the department and the University of California enter into a contract or agreement to establish the program, that the program include specified components, including, among other things, an Internet Web site designed to disseminate information to health care professionals and consumers on the relative safety and effectiveness of those drugs, as specified, and, until January 1, 2015, a prescription education service, as specified. The bill would require the department to provide an annual report on the service to specified legislative committees.
Bill Text
- Amended 05/14/09 - Amended Senate Current pdf May 14, 2009
- Amended 05/06/09 - Amended Senate pdf May 06, 2009
- Amended 03/31/09 - Amended Senate pdf March 31, 2009
- Introduced 02/25/09 - Introduced pdf February 25, 2009
- SB341 View text html
Action History
-
Returned to Secretary of Senate pursuant to Joint Rule 56.
-
Set, first hearing. Held in committee and under submission.
-
(Suspense - for vote only.)
-
Set for hearing May 28.
-
Joint Rule 62(a) file notice suspended. (Page 1036.)
-
Placed on APPR suspense file.
-
Set for hearing May 26.
-
From committee with author's amendments. Read second time. Amended. Re-referred to Com. on APPR.
-
Re-referred to Com. on APPR.
-
Withdrawn from committee.
-
Read second time. Amended. Re-referred to Com. on REV. & TAX.
-
From committee: Do pass as amended, but first amend, and re-refer to Com. on REV. & TAX. (Ayes 6. Noes 3. Page 730.)
-
Set for hearing April 29.
-
Set, first hearing. Failed passage in committee. (Ayes 5. Noes 4. Page 556.) Reconsideration granted.
-
From committee with author's amendments. Read second time. Amended. Re-referred to Com. on HEALTH.
-
Set for hearing April 15.
-
Hearing postponed by committee.
-
Set for hearing April 1.
-
To Coms. on HEALTH and REV. & TAX.
-
From print. May be acted upon on or after March 28.
-
Introduced. Read first time. To Com. on RLS. for assignment. To print.
Sponsors
- DeSaulnier · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 121 not signed on · 1 voted No
Sponsors (1)
- DeSaulnier
Co-sponsors (0)
None.
Not signed on (121)
121 members have not signed on to this bill.
Show all 121 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 13 | 0 | 0 | 0 |
| Total | 13 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (13)
| Member | Party | Vote |
|---|---|---|
| Yee | — | Yea |
| Hancock | — | Yea |
| Runner | — | Yea |
| Corbett | — | Yea |
| Kehoe | — | Yea |
| Wolk | — | Yea |
| Leno | — | Yea |
| Oropeza | — | Yea |
| Walters | — | Yea |
| Wyland | — | Yea |
| Cox | — | Yea |
| DeSaulnier | — | Yea |
| Denham | — | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 7 | 2 | 0 | 2 |
| Republican | 0 | 1 | 0 | 0 |
| Total | 7 | 3 | 0 | 2 |
| % of votes cast | 58% | 25% | 0% | 17% |
How each member voted (12)
| Member | Party | Vote |
|---|---|---|
| Negrete | — | Yea |
| Cedillo | — | Yea |
| McLeod | — | Yea |
| Pavley | — | Yea |
| Aanestad | — | Not Voting |
| Alquist | — | Yea |
| Leno | — | Yea |
| Maldonado | — | Nay |
| Wolk | — | Not Voting |
| Cox | — | Nay |
| DeSaulnier | — | Yea |
| Strickland, Tony | Republican | Nay |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 5 | 3 | 0 | 3 |
| Republican | 0 | 1 | 0 | 0 |
| Total | 5 | 4 | 0 | 3 |
| % of votes cast | 42% | 33% | 0% | 25% |
How each member voted (12)
| Member | Party | Vote |
|---|---|---|
| Cedillo | — | Not Voting |
| Negrete | — | Not Voting |
| Alquist | — | Yea |
| Leno | — | Yea |
| Maldonado | — | Nay |
| McLeod | — | Not Voting |
| Wolk | — | Yea |
| Aanestad | — | Nay |
| Pavley | — | Yea |
| Cox | — | Nay |
| DeSaulnier | — | Yea |
| Strickland, Tony | Republican | Nay |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 11 | 0 | 0 | 0 |
| Republican | 1 | 0 | 0 | 0 |
| Total | 12 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (12)
| Member | Party | Vote |
|---|---|---|
| Cedillo | — | Yea |
| Cox | — | Yea |
| Negrete | — | Yea |
| Leno | — | Yea |
| McLeod | — | Yea |
| Pavley | — | Yea |
| Wolk | — | Yea |
| Aanestad | — | Yea |
| Alquist | — | Yea |
| Maldonado | — | Yea |
| DeSaulnier | — | Yea |
| Strickland, Tony | Republican | Yea |
Subjects
Frequently asked questions
- What does SB 341 do?
- Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of food, drugs, and cosmetics, under the administration of the State Department of Public Health. This bill would require the department to make every effort to enter into a contract or agreement with the University of California to establish a program, implemented only with federal or private funds or both, to evaluate the safety and effectiveness of prescription drugs in California. This bill would require, if the department and the University of California enter into a contract or agreement to establish the program, that the program include specified components, including, among other things, an Internet Web site designed to disseminate information to health care professionals and consumers on the relative safety and effectiveness of those drugs, as specified, and, until January 1, 2015, a prescription education service, as specified. The bill would require the department to provide an annual report on the service to specified legislative committees.
- Who sponsors SB 341?
- SB 341 is sponsored by DeSaulnier.
- What is the current status of SB 341?
- This bill died with 2009-2010 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 341?
- Track SB 341 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 341
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 341
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →